Literature DB >> 10893600

A new direct test of bladder permeability.

D R Erickson1, N Herb, S Ordille, N Harmon, V P Bhavanandan.   

Abstract

PURPOSE: A proposed cause of interstitial cystitis is increased bladder permeability but to our knowledge this theory has not been proved by direct testing. We developed a safe, relatively painless, direct test of bladder permeability.
MATERIALS AND METHODS: The original permeability test involved placing 4% lactulose and 1% rhamnose intravesically, then drawing blood to assay for these sugars. Initial feasibility studies were performed in rabbits with bladder epithelium that was intact or disrupted by a 50% acetone rinse. In humans the initial goal was to distinguish intact bladders from those known to have increased permeability. Since distention is known to increase permeability temporarily, we studied patients with interstitial cystitis immediately after distention.
RESULTS: Neither sugar was absorbed from intact rabbit bladders, while each was absorbed from acetone rinsed bladders at 10, 20 and 30 minutes. We used 100 ml. of solution in the initial 8 humans, including 6 with interstitial cystitis and 2 controls. At 30 minutes each sugar was absorbed from interstitial cystitis bladders but neither was absorbed from intact bladders. The test solution was then changed to 5% rhamnose. Mean rhamnose absorption plus or minus standard deviation was much greater in the 6 patients with interstitial cystitis than in 8 controls (26.3 + or - 26.1 versus 0.78 + or - 0.87 nmol. /ml. serum, p = 0.008). With 1 exception interstitial cystitis serum levels were at least 4-fold higher than the highest control level.
CONCLUSIONS: This new permeability test clearly distinguishes intact versus distended bladders. It may be performed to test whether bladder permeability is increased in interstitial cystitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893600

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis.

Authors:  Christopher D Engles; Paul J Hauser; Shivon N Abdullah; Daniel J Culkin; Robert E Hurst
Journal:  Urology       Date:  2011-12-02       Impact factor: 2.649

2.  The role of pentosan polysulfate in treatment approaches for interstitial cystitis.

Authors:  Joel Mh Teichman
Journal:  Rev Urol       Date:  2002

3.  Standardized cranberry capsules for radiation cystitis in prostate cancer patients in New Zealand: a randomized double blinded, placebo controlled pilot study.

Authors:  Katelin Hamilton; Noelle C Bennett; Gordon Purdie; Patries M Herst
Journal:  Support Care Cancer       Date:  2014-07-04       Impact factor: 3.603

4.  Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.

Authors:  Paul J Hauser; David A Buethe; John Califano; Troy M Sofinowski; Daniel J Culkin; Robert E Hurst
Journal:  J Urol       Date:  2009-09-17       Impact factor: 7.450

Review 5.  Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis.

Authors:  Emmanuel Graham; Toby C Chai
Journal:  Curr Urol Rep       Date:  2006-11       Impact factor: 2.862

Review 6.  Interstitial cystitis: modern tools for an accurate diagnosis.

Authors:  Lisa Nipkow; Toby C Chai
Journal:  Curr Urol Rep       Date:  2003-10       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.